© Copyright 2026, All Rights Reserved
Proprietary platform for measuring gene regulators
Identify novel drug targets in oncology and rare diseases; Develop first-in-class therapeutics targeting transcription factors; Accelerate preclinical development through toxicity prediction; Collaborate on drug discovery with innovative biotech teams; Explore gene regulation mechanisms in live cell contexts.
Raised $11.2M in additional funding in 2024; Collaborates with teams pushing the boundaries of biology; Focuses on previously undruggable targets in various disease areas.